Petros Pharmaceuticals Stock Price on March 27, 2024
| PTPI Stock | USD 0.36 0 0.28% |
If you're considering investing in Petros Stock, it is important to understand the factors that can impact its price. As of today, the current price of Petros Pharmaceuticals stands at 0.36, as last reported on the 11th of December 2024, with the highest price reaching 0.36 and the lowest price hitting 0.36 during the day. Petros Pharmaceuticals is extremely dangerous at the moment. Petros Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.024, which implies the firm had a 0.024% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Petros Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Petros Pharmaceuticals' Semi Deviation of 4.22, risk adjusted performance of 0.0404, and Coefficient Of Variation of 2292.6 to confirm if the risk estimate we provide is consistent with the expected return of 0.16%.
As of now, Petros Pharmaceuticals' Total Stockholder Equity is increasing as compared to previous years. The Petros Pharmaceuticals' current Liabilities And Stockholders Equity is estimated to increase to about 41.9 M, while Common Stock is projected to decrease to 283.10. . As of now, Petros Pharmaceuticals' Price Book Value Ratio is increasing as compared to previous years. The Petros Pharmaceuticals' current Price To Book Ratio is estimated to increase to 0.33, while Price To Sales Ratio is projected to decrease to 0.50. Petros Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Petros |
Sharpe Ratio = 0.024
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PTPI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.78 actual daily | 60 60% of assets are less volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Petros Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Petros Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.0768 | Enterprise Value Ebitda (0.15) | Price Sales 0.8774 | Shares Float 9 M | Wall Street Target Price 1 |
Related Headline
Akanda Corp Headline on 27th of March 2024
Univest Securities, LLC Announces Closing of 5 Million Under... by finance.yahoo.com
New York, March 27, 2024 -- Univest Securities, LLC , a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of underwritten public offering of 3,087,443 common stock priced at 0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares with respect to the underwritten public offering for its client Akanda Corp. Akanda or the C
Petros Pharmaceuticals Valuation on March 27, 2024
It is possible to determine the worth of Petros Pharmaceuticals on a given historical date. On March 27, 2024 Petros was worth 1.48 at the beginning of the trading date compared to the closed value of 1.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Petros Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Petros Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Petros Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Petros Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.58 | 1.58 | 1.48 | 1.55 | 750,161 | |
03/27/2024 | 1.48 | 1.52 | 1.39 | 1.45 | 763,806 |
| 1.47 | 1.52 | 1.42 | 1.48 | 378,806 |
| Backtest Petros Pharmaceuticals | | | Petros Pharmaceuticals History | | | Petros Pharmaceuticals Valuation | Previous | Next |
Petros Pharmaceuticals Trading Date Momentum on March 27, 2024
| On March 28 2024 Petros Pharmaceuticals was traded for 1.48 at the closing time. The top price for the day was 1.52 and the lowest listed price was 1.42 . The trading volume for the day was 378.8 K. The trading history from March 28, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.07% . The trading delta at closing time against the current closing price is 36.55% . |
Petros Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Petros Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Petros Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Petros financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Petros Pharmaceuticals Stock history
Petros Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Petros is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Petros Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Petros Pharmaceuticals stock prices may prove useful in developing a viable investing in Petros Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.2 M | 1.4 M | |
| Net Loss | -10.3 M | -10.9 M |
Petros Pharmaceuticals Stock Technical Analysis
Petros Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Petros Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Petros Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Petros Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Petros Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Petros Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Petros Pharmaceuticals stock market strength indicators, traders can identify Petros Pharmaceuticals entry and exit signals to maximize returns
Petros Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Petros Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Petros Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Petros to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0404 | |||
| Jensen Alpha | 0.2785 | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | 0.0296 | |||
| Treynor Ratio | 7.04 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Petros Stock analysis
When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |